(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-2-hydroxybenzamide

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-2-hydroxybenzamide
• 英文别名: N-(2,5-dioxopyrrol-1-yl)-2-hydroxybenzamide
• 化学式: C₁₁H₈N₂O₄
• 分子量: 232.196
• InChiKey: HEGVDGXYWWAENX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.8
• 重原子数：
  17
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  86.7
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  水杨酸甲酯 在 一水合肼 、 溶剂黄146 作用下， 以 乙醇 为溶剂， 反应 6.0h， 生成 (2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-2-hydroxybenzamide
  参考文献：
  名称：

  新型吡唑和吡唑并[1,2-a]哒嗪作为选择性COX-2抑制剂；超声辅助合成，生物学评估和DFT计算。

  摘要：

  COX-2是一种介导炎症反应的诱导酶。COX-2的选择性靶向可用于开发无溃疡活性的抗炎药。在这里，我们报告设计和合成一系列具有选择性COX-2抑制活性和体内抗炎作用的吡唑和吡唑并[1,2-a]哒嗪。通过酸催化的超声辅助反应可以访问两个系列。这项研究中活性最高的化合物是两个新分子11和16，分别显示出有希望的选择性和16.50和20.1nM的适度IC50。这些化合物也停靠在COX-2酶的晶体结构（PDB ID：3LN1）中，以了解其结合方式。最后，使用DFT方法计算了化合物11和塞来昔布的Mulliken电荷和静电表面电势，以深入了解该化合物活性的分子决定因素。这些结果可能导致开发具有改进的选择性的新型COX-2抑制剂。

  DOI：

  10.1016/j.bmcl.2017.04.020

文献信息

• A Rational Design, Synthesis, Biological Evaluation and Structure–Activity Relationship Study of Novel Inhibitors against Cyanobacterial Fructose-1,6-bisphosphate Aldolase
  作者：Xinya Han、Xiuyun Zhu、Shuaihua Zhu、Lin Wei、Zongqin Hong、Li Guo、Haifeng Chen、Bo Chi、Yan Liu、Lingling Feng、Yanliang Ren、Jian Wan

  DOI：10.1021/acs.jcim.5b00618

  日期：2016.1.25

  In the present study, a series of novel maleimide derivatives were rationally designed and optimized, and their inhibitory activities against cyanobacteria class-II fructose-1,6-bisphosphate aldolase (Cy-FBA-II) and Synechocystis sp. PCC 6803 were further evaluated. The experimental results showed that the introduction of a bigger group (Br, Cl, CH3, or C6H3-o-F) on the pyrrole-2',5'-dione ring resulted in a decrease in the Cy-FBA-II inhibitory activity of the hit compounds. Generally, most of the hit compounds with high Cy-FBA-II inhibitory activities could also exhibit high in vivo activities against Synechocystis sp. PCC 6803. Especially, compound 10 not only shows a high Cy-FBA-II activity (IC50 = 1.7 mu M) but also has the highest in vivo activity against Synechocystis sp. PCC 6803 (EC50 = 0.6 ppm). Thus, compound 10 was selected as a representative molecule, and its probable interactions with the surrounding important residues in the active site of Cy-FBA-II were elucidated by the joint use of molecular docking, molecular dynamics simulations, ONIOM calculations, and enzymatic assays to provide new insight into the binding mode of the inhibitors and Cy-FBA-II. The positive results indicate that the design strategy used in the present study is very likely to be a promising way to find novel lead compounds with high inhibitory activities against Cy-FBA-II in the future. The enzymatic and algal inhibition assays suggest that Cy-FBA-II is very likely to be a promising target for the design, synthesis, and development of novel specific algicides to solve cyanobacterial harmful algal blooms.
• Novel pyrazoles and pyrazolo[1,2- a ]pyridazines as selective COX-2 inhibitors; Ultrasound-assisted synthesis, biological evaluation, and DFT calculations
  作者：Nagat Ghareb、Hosam A. Elshihawy、Mohamed M. Abdel-Daim、Mohamed A. Helal

  DOI：10.1016/j.bmcl.2017.04.020

  日期：2017.6

  devoid of ulcerogenic activity. Herein, we report the design and synthesis of a series of pyrazoles and pyrazolo[1,2-a]pyridazines with selective COX-2 inhibitory activity and in vivo anti-inflammatory effect. Both series were accessed through acid-catalyzed ultrasound-assisted reactions. The most active compounds in this study are two novel molecules, 11 and 16, showing promising selectivity and decent

  COX-2是一种介导炎症反应的诱导酶。COX-2的选择性靶向可用于开发无溃疡活性的抗炎药。在这里，我们报告设计和合成一系列具有选择性COX-2抑制活性和体内抗炎作用的吡唑和吡唑并[1,2-a]哒嗪。通过酸催化的超声辅助反应可以访问两个系列。这项研究中活性最高的化合物是两个新分子11和16，分别显示出有希望的选择性和16.50和20.1nM的适度IC50。这些化合物也停靠在COX-2酶的晶体结构（PDB ID：3LN1）中，以了解其结合方式。最后，使用DFT方法计算了化合物11和塞来昔布的Mulliken电荷和静电表面电势，以深入了解该化合物活性的分子决定因素。这些结果可能导致开发具有改进的选择性的新型COX-2抑制剂。